Stock Details
TAK is Takeda Pharmaceutical Company Limited's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 13.77$. Average daily volumn in 3 months 2.46M. Market cap 41.06B



Stock symbol : TAK. Exchange : NYSE. Currency : USD
Lastest price : 12.97$. Total volume : 2.86M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Takeda Pharmaceutical Company Limited (TAK)
Last Price
12.97$
Change
0.00
Volume
2.86M

Previous Close12.97
Open12.91
Day Range12.91-13.09
Bid12.75 x 900
Ask12.98 x 4k
Volume2.86M
Average Volume2.46M
Market Cap41.06B
BetaN/A
52 Week Range12.75-16.39
Trailing P/E29.48
Foward P/E6.55
Dividend (Yield %)N/A
Ex-Dividend DateN/A



Financial Details


According to Takeda Pharmaceutical Company Limited's financial reports the company's revenue in 2022 were 3.57T an increase(0%) over the years 2021 revenue that were of 3.2T. In 2022 the company's total earnings were 230.06B while total earnings in 2021 were 376B(-38.83%).


Loading ...



Organization

Market Cap:
41.06B
Revenue:
3.57T
Total Assets:
13.18T
Total Cash:
849.7B


News about "Takeda Pharmaceutical Company Limited"

takeda-pharmaceutical-company-limited-nysetak-shares-acquired-by-private-advisor-group-llc-image

Takeda Pharmaceutical Company Limited (NYSE:TAK) Shares Acquired by Private Advisor Group LLC

Source from : Defense World - 3 days ago

Private Advisor Group LLC raised its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK โ€“ Get Rating) by 26.3% during the second quarter, according to the company in its most recent ...See details»


Takeda Pharmaceutical Company Limited (TAK): Odds are Looking Good after Recent Activity

Source from : investchronicle - 3 days ago

Letโ€™s start up with the current stock price of Takeda Pharmaceutical Company Limited (TAK), which is $13.02 to be very precise. The Stock rose vividly during the last session to $12.9221 after opening ...See details»


veriti-management-llc-increases-position-in-takeda-pharmaceutical-company-limited-nysetak-image

Veriti Management LLC Increases Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Source from : Defense World - 3 days ago

Veriti Management LLC increased its stake in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK โ€“ Get Rating) by 41.5% during the second quarter, according to the company in its most recent ...See details»


Takeda Pharmaceutical Company Limited (TAK)

Source from : Yahoo Finance - 2 days ago

The initiative will draw on UNITARโ€™s experti Puma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining worldwide development and commercialization rights to ...See details»


Takeda Pharmaceutical Co. Ltd. ADR

Source from : Wall Street Journal - 2 days ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»


6Short Volatility Alert: Takeda Pharmaceutical Company Limited

Source from : Benzinga.com - 3 days ago

On Tuesday, shares of Takeda Pharmaceutical Company Limited (TAK) experienced volatile short activity. After the activity, the stock price went down -0.08% to $12.80. The overall sentiment for ILUS ...See details»


Takeda Pharmaceutical Company Limited (4502.T)

Source from : Yahoo Finance - 2 days ago

TAK vs. ZTS: Which Stock Is the Better Value Option? Puma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining worldwide development and commercialization rights to ...See details»


takeda-pharmas-india-operations-become-united-nations-global-compact-signatory-image

Takeda Pharma's India operations become United Nations Global Compact signatory

Source from : Daily - 4 days ago

Takeda Pharmaceutical Company Limited has announced that its India operations have become a signatory of the United Nations Global Compact (UNGC), the largest sustainability ...See details»


Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Source from : Nasdaq - 2 years ago

Please note that the dividend history might include the companyโ€™s preferred securities as well. Price/Earnings Ratio is a widely used stock evaluation measure. For a security, the Price ...See details»


Takeda Pharmaceuticals Company: 3D Consultations for Takeda

Source from : Warc - 2 month ago

Takeda knew from sales and primary research that there is a delay in prescribing biologics as a whole to Irritable Bowel Disease (IBD) patients โ€“ and, of course, within this sits their own unique ...See details»


Enzyme Replacement Therapy Market See Huge Growth for New Normal | Takeda Pharmaceutical Company Limited, Sanofi S.A., AbbVie Inc.

Source from : Digital Journal - 15 days ago

New Jersey (United States) The Enzyme Replacement Therapy Market research report provides all the information related to the industry. It gives the markets outlook by giving authentic data to its ...See details»


Hereditary Angioedema Market to Exhibit Skyrocketing Expansion During 2022-2028 | CSL Behring, Takeda Pharmaceutical Company Limited., Pharming

Source from : Digital Journal - 1 month ago

Find the complete Hereditary Angioedema Market analysis segmented by companies, region, type and applications in the report. The research focuses on the drivers and restraints that impact market ...See details»


DGAP-Adhoc: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate

Source from : Business Insider - 22 days ago

DGAP-Ad-hoc: Heidelberg Pharma AG / Key word(s): Alliance Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop ... and the first company to develop the ...See details»


Heidelberg Pharma Announces Conclusion of Licenseโ€ฆ

Source from : PharmiWeb - 22 days ago

Ladenburg, Germany, 9 September 2022 โ€“ Heidelberg Pharma AG (FSE: HPHA) today announced that its subsidiary Heidelberg Pharma Research GmbH and Takeda signed a license ... an oncology specialist and ...See details»